M&A

Potential Alcon sale worries Novartis investors
Drug Delivery Business News
Tue, 05/30/17 - 10:14 am
Novartis
Alcon
devices
M&A
eye health
Pharma’s Identity Crisis: Four strategies for creating value in life sciences
Pharmafile
Sat, 05/20/17 - 01:23 pm
pharma industry
R&D
M&A
competition
Astellas completes 800 million euro biotech acquisition of Ogeda
Pharma Times
Sat, 05/20/17 - 01:20 pm
Ogeda
Astellas
M&A
Thermo Fisher Extends Binge With $5.2 Billion Patheon Deal
Bloomberg
Mon, 05/15/17 - 02:01 pm
Thermo Fisher
Patheon
M&A
INC Research and inVentiv Health Merge to Form CRO Worth $7.4 Billion
Xtalks
Mon, 05/15/17 - 09:41 am
INC Research
inVentiv
CROs
M&A
GlaxoSmithKline aims for the whole consumer-health shebang with $10.3B Novartis JV buyout
Fierce Pharma
Mon, 05/15/17 - 09:20 am
consumer health
M&A
GSK
Novartis
Horizon dives into eye treatments with River Visions acquisition
BioPharma Dive
Sun, 05/14/17 - 12:56 pm
Horizon Pharma
River Visions
M&A
eye health
Sanofi is a 'satisfactory' business with no urgent M&A needs, chairman says
Fierce Pharma
Fri, 05/12/17 - 11:50 am
Sanofi
Serge Weinberg
M&A
Here's How Much Teva Pharmaceutical Could Net From the Sale of Non-Core Assets
Motley Fool
Fri, 05/12/17 - 11:46 am
Teva Pharmaceutical
M&A
Women's Health
oncology
Fresh off an M&A spree, Mylan may need another buy to keep growing: analyst
Fierce Pharma
Fri, 05/12/17 - 09:35 am
Mylan Labs
M&A
earnings
Teva, still searching for 'world-class' CEO, officially puts women's health, cancer on the block
Fierce Pharma
Thu, 05/11/17 - 06:28 pm
Teva Pharmaceutical
Pharma CEOs
M&A
Women's Health
oncology
Read my lips, Allergan CEO tells M&A-craving analysts. Don't expect a megamerger from us
Fierce Pharma
Wed, 05/10/17 - 09:33 am
Allergan
M&A
Pharma CEOs
Brent Saunders
earnings
Takeda pens GammaDelta Therapeutics $100M pact, with M&A option
Fierce Biotech
Tue, 05/9/17 - 10:21 am
Takeda
GammaDelta Therapeutics
M&A
R&D
gamma delta T cells
Shire conservative as it navigates Baxalta integration
BioPharma Dive
Wed, 05/3/17 - 02:18 pm
Shire Pharmaceuticals
Baxalta
M&A
So what’s holding back Pfizer and Gilead from the really big M&A deals we’ve all been waiting for?
Endpoints
Wed, 05/3/17 - 10:54 am
Pfizer
Gilead Sciences
M&A
Is Pfizer really weighing a BMS buy? Clues from Q1's earnings call say it just may be
Fierce Pharma
Wed, 05/3/17 - 10:09 am
Pfizer
earnings
M&A
Bristol-Myers Squibb
How Much Would Sarepta Therapeutics Fetch in a Buyout?
Motley Fool
Tue, 05/2/17 - 10:18 am
Sarepta Therapeutics
M&A
Alere, set to be acquired by Abbott, dealt setback in Medicare case
Bizjournals.com
Tue, 05/2/17 - 09:56 am
Alere
Abbott Labs
Medicare
M&A
How Far Into the Drug Pipeline Should the FTC Reach?
TheStreet.com
Mon, 05/1/17 - 10:59 am
FTC
GSK
Novartis
BRAF inhibitor
MEK inhibitor
melanoma
Array Biopharma
M&A
Sarepta CEO Exits Along With a Sanofi Director, So Let's Speculate About a Possible Deal
TheStreet.com
Fri, 04/28/17 - 11:48 am
Sarepta Therapeutics
Sanofi
M&A
Pharma CEOs
Ed Kaye

Pages